Elevated serum Cripto‐1 and VEGF levels in patients with non‐small cell lung cancer.
- Published in:
- FASEB Bioadvances, 2022, v. 4, n. 8, p. 539, doi. 10.1096/fba.2022-00002
- By:
- Publication type:
- Article
Works matching IS 25739832 AND DT 2022 AND VI 4 AND IP 8
Results: 7
1
2
Q & A with FASEB BioAdvances Editors‐in‐Chief.
- Published in:
- FASEB Bioadvances, 2022, v. 4, n. 8, p. 506, doi. 10.1096/fba.2022-00064
- By:
- Publication type:
- Article
3
Impact of a long‐term high‐fructose diet on systemic metabolic profiles of mice.
- Published in:
- FASEB Bioadvances, 2022, v. 4, n. 8, p. 560, doi. 10.1096/fba.2021-00152
- By:
- Publication type:
- Article
4
In vivo observation of multi‐phase spatiotemporal cellular dynamics of transplanted HSPCs during early engraftment.
- Published in:
- FASEB Bioadvances, 2022, v. 4, n. 8, p. 547, doi. 10.1096/fba.2021-00164
- By:
- Publication type:
- Article
5
New insights into the role of matrix metalloproteinase 3 (MMP3) in bone.
- Published in:
- FASEB Bioadvances, 2022, v. 4, n. 8, p. 524, doi. 10.1096/fba.2021-00092
- By:
- Publication type:
- Article
6
Myocardin‐related transcription factor's interaction with serum‐response factor is critical for outgrowth initiation, progression, and metastatic colonization of breast cancer cells.
- Published in:
- FASEB Bioadvances, 2022, v. 4, n. 8, p. 509, doi. 10.1096/fba.2021-00113
- By:
- Publication type:
- Article
7
Issue Information.
- Published in:
- FASEB Bioadvances, 2022, v. 4, n. 8, p. 505, doi. 10.1096/fba.1246
- Publication type:
- Article